Skip to content

The Road to Treatment Access

  • Chad Cipiti

Generic drug registration, licensing, and a trip to Gilead’s islands Karyn Kaplan and Tracy Swan Access to essential medicines is part of the human right to health. The HIV/AIDS epidemic has demonstrated that generic competition is key to massive antiretroviral…

Read more

A Drug by Any Other Name

  • Chad Cipiti

The basics of generic medications, bioequivalence, and the push for good manufacturing practices Tim Horn Securing access to generic drugs to treat HIV, hepatitis C virus (HCV), and tuberculosis (TB) is now one of the most prominent strategies of global…

Read more

TAGline Fall 2014

  • Chad Cipiti
Hello Generics: A Drug by Any Other Name; The Road to Treatment Access; Safeguarding Against Stockouts; Generics vs. the Giant
Read more

Cure Research Media Monitor

  • Chad Cipiti

Scientific research into curing HIV infection has expanded significantly in recent years, gaining a much higher profile in the press. Unfortunately, media coverage of cure research can be inaccurate and tends to overhype preliminary results. The purpose of this page…

Read more

2014 Pipeline Report

  • Chad Cipiti

July 20, 2014 HIV, HCV, and TB Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development Written by Polly Clayden, Simon Collins, Colleen Daniels, Mike Frick, Mark Harrington, Tim Horn, Richard Jefferys, Karyn…

Read more
Back To Top